Stefano Da Pozzo
Overview
Explore the profile of Stefano Da Pozzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Savo M, De Amicis M, Cozac D, Cordoni G, Corradin S, Cozza E, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274418
Coronary artery disease (CAD) is the leading global cause of mortality, accounting for approximately 30% of all deaths. It is primarily characterized by the accumulation of atherosclerotic plaques within the...
2.
Pergola V, Avesani M, Reffo E, Da Pozzo S, Cavaliere A, Padalino M, et al.
Monaldi Arch Chest Dis
. 2023 Sep;
94(1).
PMID: 37768214
The arterial switch operation (ASO) has become the standard surgical treatment for patients with d-transposition of the great arteries. While ASO has significantly improved survival rates, a subset of patients...
3.
Mattesi G, Savo M, De Amicis M, Amato F, Cozza E, Corradin S, et al.
Monaldi Arch Chest Dis
. 2023 Sep;
94(1).
PMID: 37675928
Cardiac computed tomography angiography (CCTA) has emerged as a cost-effective and time-saving technique for excluding coronary artery disease. One valuable tool obtained by CCTA is the coronary artery calcium (CAC)...
4.
Cipriani A, Mattesi G, Bariani R, Cecere A, Martini N, De Michieli L, et al.
Eur Radiol
. 2022 Jul;
33(1):270-282.
PMID: 35788758
Arrhythmogenic cardiomyopathy (ACM) is a genetically determined heart muscle disease characterized by fibro-fatty myocardial replacement, clinically associated with malignant ventricular arrhythmias and sudden cardiac death. Originally described a disease with...
5.
Celeghin R, Cipriani A, Bariani R, Bueno Marinas M, Cason M, Bevilacqua M, et al.
Heart Rhythm
. 2021 Oct;
19(2):235-243.
PMID: 34601126
Background: Mutations in filamin-C (FLNC) are involved in the pathogenesis of arrhythmogenic cardiomyopathy (ACM) and dilated cardiomyopathy (DCM), and have been associated with a left ventricular (LV) phenotype, characterized by...
6.
Iacono P, Da Pozzo S, Bedendo A, Arrigo A, Parravano M, Varano M, et al.
Eur J Ophthalmol
. 2021 Jul;
32(4):2433-2439.
PMID: 34313159
Purpose: To evaluate the superficial (SCP) and deep retinal capillary plexus (DCP) by mean of optical coherence tomography angiography (OCTA) in treatment-naïve patients affected by rheumatoid arthritis (RA). Methods: Between...
7.
Da Pozzo S, Iacono P, Arrigo A, Battaglia Parodi M
Pharmaceuticals (Basel)
. 2021 Feb;
14(2).
PMID: 33572948
Central serous chorioretinopathy (CSC) is a controversial disease both in terms of clinical classification and choice of therapeutic strategy. Choroidal layers, retinal pigment epithelium (RPE), photoreceptors, and retina are involved...
8.
Iacono P, Da Pozzo S, Varano M, Parravano M
Pharmaceuticals (Basel)
. 2020 Nov;
13(11).
PMID: 33137968
Central serous chorioretinopathy represents the fourth most frequent retinal disorder, occurring especially in young age. Central serous chorioretinopathy is mainly characterized by macular serous retinal detachment and although the clinical...
9.
Battaglia Parodi M, Iacono P, Da Pozzo S
Curr Drug Targets
. 2020 Apr;
21(12):1201-1207.
PMID: 32342816
The therapeutic approach based on anti-vascular endothelial growth factor (anti-VEGF) molecules can be used to treat two important complications of retinal dystrophies: choroidal neovascularization and macular edema. The macular involvement...
10.
Iacono P, Battaglia Parodi M, Papayannis A, Kontadakis S, Da Pozzo S, Cascavilla M, et al.
Ophthalmic Res
. 2014 May;
52(1):25-31.
PMID: 24861045
Aim: To evaluate the agreement between fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD-OCT) in detecting myopic choroidal neovascularization (CNV) activity during bevacizumab treatment. Methods: Thirty-four patients with subfoveal...